|
HY-10038-1mg
|
MedChemexpress LLC
|
A 922500 [CAS 959122-11-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-10038-10mg
|
MedChemexpress LLC
|
A 922500 [CAS 959122-11-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-10038-100mg
|
MedChemexpress LLC
|
A 922500 [CAS 959122-11-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-10038-5mg
|
MedChemexpress LLC
|
A 922500 [CAS 959122-11-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-10038-50mg
|
MedChemexpress LLC
|
A 922500 [CAS 959122-11-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100382-10mg
|
MedChemexpress LLC
|
FPTQ [CAS 864863-72-9]
|
|
|
|
|
HY-100382-25mg
|
MedChemexpress LLC
|
FPTQ [CAS 864863-72-9]
|
|
|
|
|
HY-100382-5mg
|
MedChemexpress LLC
|
FPTQ [CAS 864863-72-9]
|
|
|
|
|
HY-100382-50mg
|
MedChemexpress LLC
|
FPTQ [CAS 864863-72-9]
|
|
|
|
|
HY-100405-1mg
|
MedChemexpress LLC
|
FTIDC [CAS 873551-53-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100405-10mg
|
MedChemexpress LLC
|
FTIDC [CAS 873551-53-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100405-5mg
|
MedChemexpress LLC
|
FTIDC [CAS 873551-53-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100432-10mg
|
MedChemexpress LLC
|
LOC14 [CAS 877963-94-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100432-100mg
|
MedChemexpress LLC
|
LOC14 [CAS 877963-94-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100432-25mg
|
MedChemexpress LLC
|
LOC14 [CAS 877963-94-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100432-5mg
|
MedChemexpress LLC
|
LOC14 [CAS 877963-94-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100432-50mg
|
MedChemexpress LLC
|
LOC14 [CAS 877963-94-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100449-1mg
|
MedChemexpress LLC
|
AL-8810 [CAS 246246-19-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-100483-1mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
|
HY-100483-10mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
|
HY-100483-100mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
|
HY-100483-25mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
|
HY-100483-5mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
|
HY-100483-50mg
|
MedChemexpress LLC
|
A-804598 [CAS 1125758-85-1]
|
|
Cancer-programmed cell death
|
|
|
HY-100534-1mg
|
MedChemexpress LLC
|
IDE 2 [CAS 1136466-93-7]
|
|
|
|
